Binex Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
59,513
59,892
71,138
80,924
78,026
Cost of Goods Sold (COGS) incl. D&A
40,092
35,694
38,843
52,608
50,360
Gross Income
19,422
24,199
32,295
28,316
27,666
SG&A Expense
23,459
21,365
25,603
30,020
35,162
EBIT
4,351
2,598
6,329
-
7,830
Unusual Expense
2,223
3
4,414
781
1,151
Non Operating Income/Expense
1,712
141
4,103
415
1,028
Interest Expense
1,539
654
1,219
1,838
1,934
Pretax Income
5,880
2,778
2,389
3,703
11,752
Income Tax
988
955
4,951
621
731
Equity in Affiliates
2,342
7,574
528
-
-
Consolidated Net Income
2,550
9,397
6,813
3,081
11,021
Net Income
2,434
9,397
6,813
3,081
11,021
Net Income After Extraordinaries
2,434
8,520
6,813
3,158
10,748
Net Income Available to Common
2,434
10,013
6,813
3,005
11,295
EPS (Basic)
102.00
394.00
232.00
98.00
367.00
Basic Shares Outstanding
24
25
29
31
31
EPS (Diluted)
101.71
404.75
231.64
97.69
367.27
Diluted Shares Outstanding
24
25
29
31
31
EBITDA
1,597
8,801
12,669
6,096
1,143
Other Operating Expense
314
236
362
283
334
Non-Operating Interest Income
521
689
1,017
451
422
Minority Interest Expense
116
-
-
-
-
Equity in Affiliates (Pretax)
-
-
-
38
232

About Binex Co.

View Profile
Address
368-3 Dadae-ro
Busan BU 49469
Korea, Republic Of
Employees -
Website http://www.bi-nex.com
Updated 09/14/2018
BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. It operates through the following business divisions: Bio, Pharmaceutical Manufacruing and Sales, and others. The bio division provides bio pharmaceutical consignment production and bio analysis services.